SAFETY AND EFFICACY OF ORAL TRIAZOLAM IN CHILDREN
SAFETY AND EFFICACY OF ORAL TRIAZOLAM IN CHILDREN
批准号:
2408774
负责人:
HELEN KARL
金额:
$3.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 1999-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The safety and efficacy of most oral benzodiazepines for sedation of
children is unknown. Yet, there is ample evidence that adverse
events occur with unfortunate regularity during sedation in dental
care settings with children. This study is a randomized double blind
clinical trial where 96 three-to-five year-old children are assigned to
either active drug (o.015 or 0.03 mg/kg) or placebo before dental
treatment. The objective of the research is to establish the efficacy,
safety, and optimal dosing regimen for oral triazolam in pediatric
sedation, a paradigm for surgical premedication, in order to provide
a rational clinical pharmacological basis for the use this drug which
is commonly used yet currently unapproved. The specific aims are:
a. To determine the efficacy of oral triazolam administered as a
premedication to children in dental practice in comparison to a
placebo.
b. To assess the safety of oral triazolam in children.
c. To study visual and memory side effects of triazolam in children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文